Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event
Modern Pathology2009Vol. 22(9), pp. 1169–1175
Citations Over TimeTop 10% of 2009 papers
I‐Tien Yeh, Mathew A Martin, Ryan S. Robetorye, Aswani R. Bolla, Chris McCaskill, Rashmi Shah, M. Gorre, Mansoor S Mohammed, Shelly Gunn
Related Papers
- → Chromosomal aberrations, visualized using UroVysion® fluorescence in-situ hybridization assay, can predict poor prognosis in formalin-fixed paraffin-embedded tissues of cholangiocarcinoma patients(2022)6 cited
- Detection of chromosome 11q13 amplification in head and neck cancer using fluorescence in situ hybridization.(1999)
- → MSX2 copy number increase and craniosynostosis: copy number variation detected by array comparative genomic hybridization(2012)9 cited
- → 415c: Serial Polysomy Fluorescence in Situ Hybridization (FISH) Results in Patients With Primary Sclerosing Cholangitis (PSC)(2010)
- → P2.02-024 False Positivity Due to Polysomy in Fluorescence in Situ Hybridization(2017)